Objectives: In this single-blind, clinical trial, we try to determine the effects of “Acoustic Wave Therapy” on abdominal fat and weight of people with obesity in comparison to the control group.
Design: The sample size would be 100 women in the age range of 35-45 years with a BMI of >30 kilogram per square meter. We will allocate the participants to two groups of cases and controls by convenient sampling from the population of people who have been referred to the clinic. The participants need to satisfy the two above-said criteria and have cellulite type II in the abdominal skin.
Methods: The duration of the study will be 1.5 months. We will measure or calculate the body composition of the participants include whole body fat and also the fat mass in the abdominal region, weight, waist circumference and Body Mass Index before and after the study period. Fifty person in the case group will take diet plus aerobic exercise and acoustic wave therapy on abdomen region and fifty person in control group will take diet plus aerobic exercise without acoustic wave therapy. At the beginning and after 1.5 months of treatment we will measure changes of weight, whole body fat, abdominal fat and wrist circumference.
Intervention: Case group Will have weight loss diet (1200-1500 Kcal with 55% carbohydrate, 20% protein and 20% fat)+one hour aerobics exercise+"Acoustic Wave Therapy" on abdominal site for 10 sessions, twice a week, 4000 pulses, frequency of 16 Hz, energy of 1.4 to 2.6 bar by D-ACTOR 200(STORZ MEDICAL AG, Switzerland). Case group: Will have weight loss diet (1200-1500 Kcal with 55% carbohydrate, 20% protein and 20% fat)+one hour aerobics exercise, without using "Acoustic Wave Therapy".
Main outcome measures: The body composition analyzer measures the whole fat mass and abdominal fat mass through measuring and comparing the bio-impedance among different tissues. Weight will be measured using a scale and waist circumference will be measured by a meter strip. BMI will be calculated through weight divided by height squared (Kg/m2) before and after treatment.
Inclusion criteria: Female; age range 35-45 years; Body Mass Index>30 kilogram/m2; diagnosed with the cellulite grade II in the skin of abdomen.
Exclusion criteria: Diabetes; hypertension; cardiovascular disease; liver disease; blood clotting disorders; hypothyroidism; varicose vein;, skin disease; cancer; favism; asthma; using some blood- thinning medications.